Annual Revenue Growth (Last Twelve Months): Assembly Biosciences (ASMB)

Graphic logo of Assembly Corp (ASMB)

Assembly Biosciences aims to capture the global hepatitis B therapy market through the development of unique patents. Revenue volatility compared to the same period last year for the TTM reflects sales dynamics, where the value of 79.90 represents the latest figure. Current cash flow remains volatile prior to product commercialization, while operational flexibility is maintained by outsourcing drug synthesis to certified external laboratories.

Sales Growth YoY (TTM): Assembly Biosciences (ASMB) for 02/11/2024 - 11/15/2026

Assembly Biosciences, Inc. (ASMB) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Price Assembly Corp|ASMB - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Assembly Bio|ASMB - Total Company Value
- balance sheet equity data:
Net Assets per Share Assembly Biosciences|ASMB - Book Capitalization|Market-to-Book Ratio assemblybio.com|ASMB - Aggregate Company Assets
- debt level and financial liquidity data:
Total Debt to Equity Ratio Assembly Biosciences|ASMB - Long-Term Debt to Capital|Short-Term Debt to Equity Assembly Bio|ASMB - Company Debts|Debt to Book Capitalization Ratio Assembly Biosciences Inc|ASMB - Company Long-Term Liabilities|Short-Term Debt Assembly Biosciences|Intermediate Coverage Ratio assemblybio.com
- company profitability and valuation multiples indicators:
ASMB - Net Profit|Expected Profit Assembly Biosciences|ASMB - P/E Multiple|Market Cap to Projected Earnings assemblybio.com|ASMB - Price/Earnings to Growth Ratio|Company Value to EBITDA Assembly Bio|ASMB - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters Assembly Biosciences|ASMB - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months assemblybio.com|ASMB - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Assembly Biosciences
- sales revenue and business income indicators:
ASMB - Revenue and Sales Volume|Company Expected Sales Volume Assembly Corp|ASMB - Price-to-Revenue Ratio|Market Cap to Projected Revenue Assembly Biosciences, Inc.|ASMB - Sales Growth YoY (TTM)
Analysis of all company metrics:Assembly Biosciences (ASMB)
Mass-produced product of assemblybio.com

Investors utilize this indicator as a leading signal of market expansion to assess business scaling rates. The metric measures the percentage deviation of current twelve-month revenue from the same period last year, which, in terms of rolling year-over-year relative revenue change, reflects the efficiency of Assembly Biosciences (ASMB) diversified hubs in supporting clinical trials.

Competitor analysis for Assembly Biosciences

Sales Growth YoY (TTM) Arrowhead Corp ARWR|mirumpharma.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Dynavax|ABUS: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Inventiva SA (IVA)|GYRE (gyretx.com) - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Galectin Therapeutics GALT|Sales Growth YoY (TTM) GNFT|Revenue Growth YoY (Last 12 Months) DURECT Corp. DRRX|Sales Growth YoY (Last Twelve Months) aligos.com ALGS|biovieinc.com (BIVI) - Trailing Twelve Months Revenue Growth|GLMD: Revenue Growth YoY (Last 12 Months)|NDRA: Sales Growth YoY (Last Twelve Months)|Hepion Pharmaceuticals, Inc. (HEPA) - Sales Growth YoY (Last Twelve Months)